What happened
Magnera Corporation (NYSE: MAGN) repaid $122 million in debt in the fiscal year ended Sept. 26, 2026, but swung to a $37 million GAAP operating loss from a $5 million profit. The materials supplier generated $178 million in operating cash, up from $103 million a year earlier, giving it more room to cut debt.
Adjusted EBITDA rose in both the fourth quarter and the full year, even as Magnera posted operating losses in both periods. A $106 million charge for goodwill and other impairment counted toward both losses. Magnera recorded the entire charge in the fourth quarter.
Explain the financial terms
A fiscal quarter is a three-month period in the company's reporting year.
Why it matters
Debt repayments slightly exceeded the $115 million Magnera had left in free cash flow after investing in property and equipment.
Current and long-term debt fell to $1.85 billion from $1.95 billion a year earlier. Cash and equivalents also fell, to $294 million from $305 million.
OptimistFi's turnaround case hinges on whether the combined materials business can generate cash consistently, not just grow sales. One year of stronger cash flow shows progress, but the operating loss keeps the evidence mixed.
How adjusted earnings rose
Fourth-quarter adjusted EBITDA rose 8.0% to $97 million from a year earlier. Magnera posted a $90 million GAAP operating loss, compared with a $10 million profit a year earlier.
Magnera said selling prices improved relative to costs, accounting for most of the quarterly gain in adjusted EBITDA. It credited Project CORE and benefits from the merger in both reporting regions.
Full-year adjusted EBITDA reached $378 million, up from $354 million as reported in fiscal 2025. The gain held after adjusting for currency and deal effects. On that basis, fiscal 2025 adjusted EBITDA was $365 million.
Explain the financial terms
A fiscal quarter is a three-month period in the company's reporting year.
Higher prices and lower volumes
Fourth-quarter sales rose to $851 million from $839 million a year earlier, even as organic volume fell. Higher prices added $43 million to sales, mainly because Magnera passed on higher raw material costs.
Organic volume fell 4.0% from a year earlier. Magnera cited weaker healthcare demand in the Americas and continued market weakness in Europe as the main reasons.
Fiscal 2026 sales of $3.3 billion topped the $3.2 billion Magnera reported for fiscal 2025. But they fell short of the prior year's $3.42 billion after adjusting for currency and deals.
Explain the financial terms
A fiscal quarter is a three-month period in the company's reporting year.
Fiscal 2027 outlook
Magnera expects operating cash flow to rise to $195 million to $215 million in fiscal 2027. It plans $85 million in net investment in property and equipment, up from $63 million in fiscal 2026.
Magnera expects adjusted EBITDA to rise to between $390 million and $410 million. It forecasts $110 million to $130 million in free cash flow, a range that puts it either below or above fiscal 2026.
What's next
Magnera's next quarterly report will show whether operating cash flow can keep rising from a year earlier while debt falls from its fiscal 2026 year-end level.

